INTRODUCTION
Regulatory T (Treg) cells play an essential role in the maintenance of immune tolerance by suppressing excessive immune responses. 1 Although B cells are generally considered the effector cells in an immune response, functionally specific B cells with a tolerogenic role, referred to as regulatory B cells, participate in the induction of immune tolerance. 2, 3 The lack or loss of regulatory B cells leads to exacerbation of the symptoms in several animal models such as non-obese diabetic, chronic colitis and collagen-induced arthritis. [4] [5] [6] Currently, there are no definite surface markers or master transcription factors to identify regulatory B cells; they are functionally defined by their immune-suppressive action in vitro or in vivo. Functional studies indicate that regulatory B cells can actively modulate immune responses through mechanisms involving cell-cell interactions and cytokine production, especially through IL-10. 7 With the ability to influence CD4 1 T cells through cytokine production and direct cell-cell interactions, whether B cells can promote the conversion of effector T cells into Treg cells has been discussed recently. In the past few years, several in vitro coculture experiments have shown that B cells have the ability to induce the generation of Treg cells and expand Foxp3 1 CD4 1 T cells in the absence of exogenous cytokines. [8] [9] [10] Antigen-loaded B cells isolated from Peyer's patches have also been shown to have the potential to induce suppressive Treg cells. 11 In the above-mentioned studies, purified splenic CD19 1 or B220 1 B-2 cells were investigated. 9, [11] [12] [13] On the other hand, although CD5 1 B-1a cells have been regarded as regulatory B cells, 14 direct evidence showing that CD5
1 B-1a cells might induce Treg cells is lacking. Thus far, whether B-1a cells play a functionally similar or different immune modulatory role with the reported B-2 cells in promoting Treg cell induction remains unclear.
In several in vitro Treg cell induction studies, especially the induction of the IL-10-producing type 1 Treg (Tr1) cell lineage, IL-10 is indispensable. [15] [16] [17] Tr1 differentiation can be driven by immature or tolerogenic dendritic cells (DCs) through IL-10. 13, 14 In vitro-cultured naive CD4 1 T cells with self-APCpulsed antigens in the presence of IL-10 induce a population of murine CD4
1 cells that contains a high number of Tr1 cells. 15 Recently, genetically modified B cells have been used to confer long-term, IL-10-dependent and antigen-specific unresponsiveness by inducing IL-10-producing Treg cells. 18 Among the B-cell subsets, peritoneal B-1a cells were first identified to have the ability to produce IL-10. 19 B-1a cells can spontaneously secrete IL-10, and the production of IL-10 can increase in response to the stimulation. 19 In contrast, conventional B-2 cells do not constitutively express IL-10 and only produce small amounts of IL-10 after interacting with T cells. 19 Therefore, we want to investigate whether IL-10-producing B-1 cells might have the ability to induce Treg cells, especially the Tr1-like cell lineage, in this study.
Here, we demonstrated that B-1a cells have the regulatory ability to convert naïve CD4 1 
T cells into Treg cells, as previously reported B-2 cells do. The Treg cells induced by B-1a cells were IL-10-producing, Foxp3
2 Treg cells and expressed the Treg-associated markers ICOS, PD-1, OX40 and IL-10R. However, B-1a cells promoted the induction of Treg through CD86-mediated cell contact, but not IL-10, which was different from the IL-10-dependent induction of Tr1 cells. In addition, while Tr1 cells mediated suppression via IL-10, the effector function of B-1a cell-induced Treg cells was mediated by soluble factors other than IL-10 or TGF-b. Taken together, we identified a previously unrevealed role of B-1a cells in controlling immune homeostasis through induction of the functionally unique Foxp3
2 Treg subsets, which has not been described before.
MATERIALS AND METHODS
Mice BALB/c mice were from the Laboratory Animal Center, College of Medicine, National Taiwan University. OVA-TCR transgenic (DO11.10) mice, BALB/c IL-10 2/2 and Foxp3/GFP reporter mice were purchased from Jackson Laboratory. DO11.10 mice with transgenic T-cell receptors recognized the 323-339 peptide fragments of ovalbumin (OVA). The Foxp3-GFP reporter mice were crossed with the DO11.10 mice to obtain Foxp3-GFP3DO11.10 F1 mice. All mice were housed in a conventional environment at the Laboratory Animal Center, College of Medicine, National Taiwan University. All experiments using these mice were approved by and performed according to the guidelines of the Animal Research Committee of the College of Medicine, National Taiwan University.
Cell preparation
The B-1a (CD90 2 CD5 1 ) and B-2 (B220 1 ) cells were isolated from peritoneal washout cells and splenocytes of BALB/c mice.
CD4
1 CD25 2 T (T naive ) and CD4 1 CD25 1 Foxp3 1 T (nTreg) cells were isolated from splenocytes of DO11.10 or BALB/c mice. To purify each cell population, positive or negative selection was performed using the BD IMag cell purification system (BD Pharmingen, San Diego, CA, USA) according to the manufacturer's instructions. The isolated cell populations were reanalyzed by flow cytometry, and the purity of the purified cells is shown in Supplementary Figure 1 .
In vitro generation of Treg-of-B cells Under antigen-specific stimulation, purified B-1a and B-2 cells were pre-treated with 10 mg/ml OVA peptide for 1 day, and CD4
1

CD25
2 T cells from DO11.10 mice were added into the culture at a 1 : 1 (B/T) ratio. In some of the experiments, purified B-1a and B-2 cells were cultured with CD4
1
CD25
2 T cells at a 1 : 1 (B/T) ratio in the presence of 2 mg/ml anti-CD3/CD28 monoclonal antibodies for 3 days. After 3 days of coculture, the CD4 1 T cells were isolated by negative selection using magnetic beads conjugated to anti-CD19 or anti-B220 antibodies (BD Pharmingen) to remove the B-1a and B-2 cells. The purity of the isolated CD4
1 T cells was measured by surface staining using anti-CD4-FITC antibodies and then analyzed by flow cytometry.
In vitro generation of Th1, Th2 and Tr1 cells For in vitro differentiation of mouse Th1 and Th2 cells, naive CD4
1 T cells were stimulated with 5 mg/ml anti-CD3 (platebound) and 1 mg/ml anti-CD28 in the presence of IL-2, IL-12 (20 ng/ml for each) and anti-IL-4 (10 mg/ml) or in the presence of IL-2 (20 ng/ml), IL-4 (100 ng/ml), anti-IFN-c and anti-IL-12 (10 mg/ml for each). To generate Tr1 cells, CD4
1 T cells from DO11.10 mice were cultured with OVA peptide (1 mg/ml) and irradiated splenic APCs in the presence of IL-10 (100 U/ml). The stimulation was repeated weekly for three constitutive weeks. The percentage of IL-10-producing Tr1 cells was determined using FACS.
Flow cytometry and cell sorting
To stain cell-surface markers, the following fluorescence-conjugated monoclonal antibodies were used: anti-CD4 (GK1.5), anti-CD5 (53-7.3), anti-CD19 (1D3), anti-CD25 (PC61.5), anti-CD90.2 (30-H12), anti-B200 (RA3-6B2), anti-CTLA-4 (UC10-4B9), anti-GITR (DTA-1), anti-ICOS (15F9), anti-OX40 (OX-86), anti-FasL (MFL3) and their respective isotype controls were obtained from eBioscience (San Diego, CA, USA); anti-IL-10R (1B1.3a) and anti-TNFRII (TR75-89) were from BD Pharmingen; and anti-PD-1 (RMP1-30), anti-TGF-b1 (TW7-20B9) and their respective isotype controls were from BioLegend (San Diego, CA, USA). Flow cytometric analysis was performed using a BD FACSCalibur (BD Biosciences, San Jose, CA, USA).
Intracellular cytokine staining
The intracellular expression of IFN-c, IL-4, IL-10 and IL-17 in Tr1 and Treg-of-B1a cells was analyzed using the Cytofi/ Cytoperm Kit Plus (BD Biosciences) according to the manufacturer's instructions. In brief, cells were incubated with PMA (50 ng/ml; Sigma, Deisenhofen, Germany), ionomycin (1 mg/ml; Sigma, Deisenhofen, Germany) and GolgiStop (BD Biosciences) B-1a cells induce Treg cells independent of IL-10 LH Hsu et al at 37 uC for 4 h. For intracellular Foxp3 staining, after fixation and permeabilization using Fix and Perm reagents (BioLegend), respectively, the cells were washed in 1.5 ml wash buffer which was provided with the kit, and then stained with the PE antimouse/rat Foxp3 staining set (eBioscience) according to the manufacturer's instructions. In the indicated experiments, to reach a greater purity, CD4 ) were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) and cultured with Treg-of-B cells in the presence of OVA peptide (10 mg/ ml) and 1310 5 irradiated splenocytes (3000 cGy) or Con A mitogen (2 mg/ml) for 72 h. nTreg cells were used as a suppressor control. Cell division was assessed by CFSE dilution and analyzed by flow cytometry. In some experiments, the proliferation was assessed by [ 2 CD5 1 B-1a and B220 1 B-2 cells were isolated from peritoneal wash-out cells and splenocytes, respectively. Purified B-1a and B-2 cells were pre-treated with OVA peptide for 1 day, and CD4
1
CD25
2 T cells from DO11.10 or Foxp3-GFP3DO11.10 mice were added at a 1 : 1 ratio. Detection of cytokine secretion by ELISA To assay cytokine secretion, purified CD4 1 CD25 2 T, Treg-ofB1a and Treg-of-B2 cells were restimulated with plate-bound anti-CD3/CD28 mAb (2 mg/ml) for 48 h. IL-4, IL-10, IFN-c and TGF-b in cell supernatant was collected and analyzed using ELISA kits (R&D, Minneapolis, MN, USA) according to the manufacturer's instructions.
Reverse-transcription and real-time PCR
In vitro-cultured Th1, Th2, purified nTreg, Treg-of-B1a and Treg-of-B2 cells were collected and lysed using TRIzol reagent (Invitrogen, Karlsruhe, Germany). An aliquot of total RNA (2 mg) was reverse transcribed to cDNA using RevertAid Reverse Transcriptase (MBI, Fermentas, EU) according to the manufacturer's instructions. Real-time PCR with SYBR green detection was performed using an ABI Step One Plus thermocycler with fluorescence detection (Applied Biosystems, Foster City, CA, USA), and the following primers were used: Foxp3:
F: 59-TACCACAATATGCGACCC-3,9 R: 59-CTCAAATT-CATCTACGGTCC-39; T-bet: F: 59-ACCAGAACGCAGAG-ATCACTCA-39, R: 59-CAAAGTTCTCCCGGAATCCTT-39; and GATA-3: F: 59-CTACCGGGTTCGGATGTAAGTC-39, R: 59-GTTCACACACTCCCTGCCTTCT-39. Appropriate no-RT and no-template controls were included in each 96-well PCR reaction, and dissociation analysis was performed at the end of each run to confirm the specificity of the reaction. The absolute levels of RNA were calculated from a standard curve established using the cDNA standards carried out during the real-time polymerase chain reaction (PCR) assay. The data are presented as normalized to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Statistical analysis
The data were analyzed for statistical significance using Student's t-test. Where indicated, statistically significant differences were determined by one-way Analysis of Variance (ANOVA) followed by Bonferroni's multiple comparison tests. *P,0.05; **P,0.01; ***P,0.001; not significant (n.s.) indicates P.0.05 for select comparisons. Values for all measurements were expressed as the mean6s.d..
RESULTS
B-1a cells convert naive CD4
1 T cells into The signatures of Treg-of-B1a cells resemble those of Tr1 cells Furthermore, we investigated whether B-1a cells also promoted the differentiation of other T effector lineages in a coculture system. We analyzed T-bet, GATA-3 and Foxp3 mRNA expression in CD4 1 CD25 2 T cells after coculturing with B cells and compared the results with those of CD4 1 CD25 2 T cells cultured in conditions promoting Th1 and Th2 differentiation. The results showed that the expression of T-bet, GATA-3 and Foxp3 was nearly undetectable in Treg-of-B1a cells and was significantly lower compared with in vitro-cultured Th1, Th2 and nTreg cells (Figure 2a) . Similarly, the expression of T-bet, GATA-3 and Foxp3 was almost undetectable in Treg-of-B2 cells (Figure 2a ). In the in vitro induction system, Tr1 cells could be identified based on their unique pattern of cytokine production, but lacked defined cell surface markers. We next examined the cytokine signatures of Foxp3 
CD25
2 T cells after coculturing with B cells (Figure 3a) , suggesting these T cells acquired an activation phenotype. Therefore, the CD25 expression level of Treg-of-B1a cells was induced by the stimulation of B cells and thus, might be different from the constitutive expression of CD25 on nTreg cells. Next, to further characterize the Treg-of-B1a cells, we used a number of molecules reported to be associated with the functions of Treg cells. [22] [23] [24] [25] [26] [27] [28] [29] [30] We found that Treg-of-B1a cells expressed a series of surface molecules, including ICOS, PD-1, GITR, OX40, IL-10R and TNFR2 (Figure 3b ). Among them, ICOS, GITR, IL-10R and PD-1 were expressed at higher levels (Figure 4a ). Therefore, B-1a cells are the major IL-10-producing cell population present in the steady-state peritoneal cavity, and they spontaneously produce IL-10 without any stimulation. Next, we analyzed the IL-10 expression by B-1a and B-2 cells at the single-cell level when they were used as APCs in our coculture system. We collected total cells from T1B-1a cocultures 3 days later and found that the major IL-10-producing cells were CD19 1 (Figure 4b ). The results suggested that B-1a cells continuously produce IL-10 after contact with CD4 1 T cells. On the other hand, the percentage of IL-10-producing cells in T1B-2 cocultures were relatively low ( Figure 4b (Figure 5a ). These results indicated that IL-10 was not required for the Treg induction process mediated by B-1a or B-2 cells. Next, B-1a cells were separately cultured with CD4 1 CD25 2 T cells to determine whether cell-cell contact was required for the induction of Treg-of-B1 cells. The results showed that a lack of cell-cell contact between B-1a and CD4
1 T cells failed to induce functionally suppressive Treg-of-B1a cells, regardless of the effect of IL-10 ( Figure 5b) . Therefore, the induction of Treg-of-B1a cells required contact through costimulatory or co-inhibitory molecules, but did not involve IL-10. Likewise, cell-cell contact was also required for the induction of Treg-of-B2 cells (Figure 5c ). When we applied blocking Abs targeting the costimulatory molecules on B-1a and B-2 cells, the results showed that blockage of CD86 on B-1a cells failed to induce functional Treg-of-B1a cells (Figure 5d ). On the other hand, both CD86 and CD80 molecules were required for B-2 cells to induce functional Treg-of-B2 cells (Figure 5e ). Taken together, the induction of Treg-of-B1a cells required an interaction between B-1a and T cells and might be regulated to different degrees by costimulatory molecules when compared with the induction of Treg-of-B2 cells.
Treg-of-B1a cells exert suppressive function via an IL-10-and TGF-b-independent pathway nTregs efficiently suppress Teff proliferation through mechanisms requiring cell-cell interactions, 31 whereas inducible Tr1 cells mediate suppression mainly through secreting IL-10.
18,31
Next, we analyzed the suppressive mechanism of Treg-of-B1a cells. To investigate the requirement of IL-10, WT B cells were cultured with WT or IL-10 2/2 (KO) CD4 1 CD25 2 T cells to generate Treg-of-B cells. Meanwhile, the contact dependency of suppression was examined using a Transwell system. The results showed that KO Treg-of-B1a cells suppressed the proliferation of responder T cells as effectively as WT Treg-of-B1a cells (Figure 6a ). In the presence of a Transwell insertion, the suppression mediated by KO Treg-of-B1a cells was still observed (Figure 6a ). These results suggested that the suppressive mechanisms of Treg-of-B1a cells were through secreting soluble factors other than IL-10. On the contrary, KO Tregof-B2 cells remained suppressive, but the suppressive capacity was completely abolished in the presence of a Transwell insertion (Figure 6b ). When we examined the suppressive mechanism of Tr1 cells, neutralization of IL-10 in the suppression assay significantly reversed the suppressive effect (Figure 6c ). In contrast, neutralization of IL-10 had no significant effect to the suppression of Treg-of-B1a cells (Figure 6c ). In addition to IL-10, the suppressive cytokine TGF-b has been shown to contribute to the suppression of Treg cells. We observed that Tregof-B1a cells produced low levels of TGF-b (Figure 2b) , and further neutralization of TGF-b had no significant effect on the suppression of Treg-of-B1a cells (Figure 6d) . Collectively, our results demonstrated that Foxp3
2 Treg-of-B1a cells belonged to a unique Treg subset that was different from the reported Tr1 cells.
B-1a cells induce Treg cells independent of IL-10
LH Hsu et al DISCUSSION Inducible Treg cells can be generated from mature T-cell populations under certain antigenic stimulation conditions, or they can be induced ex vivo by culturing naive CD4 1 T cells with antigen or polyclonal activators in the presence of immunosuppressive cytokines. 32 Among the diverse Treg populations, Tr1 cells specifically arise from naive precursors in the presence of IL-10.
33
Tr1 differentiation can be driven by immature or tolerogenic DCs through an IL-10-dependent mechanism or by self-APCpulsed antigens in the presence of IL-10. 17, 19 With the ability to produce high levels of regulatory cytokines such as IL-10, B-1a cells are considered B cells with regulatory function. 33 We showed that B-1a cells were potent IL-10-producing cells at steady state when compared with the conventional B-2 subsets (Figure 4a ). Moreover, B-1a cells interacted with CD4 1 T cells as APCs, leading to a larger amount of IL-10 production in in vitro cocultures (Figure 4b and c) . While most studies have emphasized the immune regulatory role of IL-10-producing B-1a cells, the ability of B-1a cells to promote the induction of Tr1 cells directly through IL-10 secretion has not been studied.
In this study, we demonstrated that B-1a cells were potent regulatory cells that can convert CD4 1 T cells into T cells with suppressive function under antigen-specific stimulation or aCD3/28 mAb stimulation (Figures 1b and 5a ). To our The results are the means6s.d. of three independent experiments. Significant differences were calculated using a one-way ANOVA followed by Bonferroni's post-test. ***P,0.001. Ab, antibody; MFI, mean fluorescence intensity; Treg, regulatory T.
knowledge, this is the first report to show that peritoneally isolated B-1a cells were able to induce Treg cells using a direct in vitro coculture strategy. Data from one report showed that B1a cells enriched IL-10-, IL-4-and IFN-c-producing T cells when they were used as APCs in vitro. Another similar study also demonstrated that B-1a cells are prone to promote Th1 and Th17 cell differentiation (measured by the intracellular IFN-c and IL-17) and generate fewer Foxp3
1 Treg cells than splenic B-2 cells. 34 In our studies, we showed that CD4 So far, a defined cell surface signature has not been identified for Tr1 cells, and their characterization has thus relied on their unique cytokine production profile. Tr1 cells secrete high levels of IL-10 and minimal amounts of IL-4 and IL-17, which distinguishes them from Th2 and Th17 cells. 21 Furthermore, depending on the local cytokine milieu, Tr1 cells can produce variable levels of IFN-c. 21 Another feature of Tr1 cells is that they do not express the transcription factor Foxp3. 32 On the contrary, nTreg cells will constitutively express Foxp3 at a level that is closely related to their suppressive ability. 31 We found that Foxp3
2 Treg-of-B1 cells produced high levels of IL-10 and IFN-c but little IL-4 (Figure 4b-d) , which suggested that they resembled Tr1 populations.
To study the features of Treg-of-B1a cells, we compared the induction process mediated by B-1a cells with that of IL-10-dependent induction of Tr1 cells. Surprisingly, we found 
CD25
2 T cells at a 1 : 1 ratio under Con A (2 mg/ml) stimulation for 72 h and analyzed for suppressive function. The cell proliferation in a-e was accessed by [ 3 H]-thymidine incorporation assays. Data are shown as the means6s.d. and are pooled from three independent experiments. Significant differences in a-e were determined using Student's t-test. *P,0.05; **P,0.01; ***P,0.001; not significant (n.s.) indicates P.0.05, compared to the T-stimulated group. Ab, antibody; Treg, regulatory T; WT, wild-type. 31 However, the effects of targeting these molecules in the in vitro suppression assay vary depending on the type of Treg cell, and the suppression might be coregulated by several regulators. Therefore, which particular molecules are involved in the suppression of Treg-of-B1a cells will be our major focus of future studies using a broad panel of screening 
2 T (T naive ) cells in the presence of TGF-b neutralizing Abs (10 mg/ ml). The cell proliferation in (a-d) was accessed by [ 3 H]-thymidine incorporation assays. The data are represented as the means6s.d. of three independent experiments. Significant differences were determined using Student's t-test. *P,0.1; compared to the T-stimulated group. Ab, antibody; Treg, regulatory T; WT, wild-type.
assays. By far, we showed that the phenotype of Treg-of-B1a cells is very much similar to that of Treg-of-B2 cells. The major difference noted between these two Treg populations was their suppressive mechanisms. While the suppressive function of Treg-of-B2 cells was potentiated by contact with responder T cells, the suppressive ability of Treg-of-B1a cells was solely facilitated by soluble factors (Figure 6a and b) . This difference might imply that Treg cells induced by B-1a and B-2 cells regulate distinct immune responses. In addition, Treg-of-B1a cells mediated suppression via soluble factors, suggesting the inhibition might act on various cell types and might not be limited by the timing and frequency of physical contact. The parallel studies performed by our group demonstrated that the in vivo function of Treg cells generated by different B-cell subsets, including splenic B-2 and Peyer's patch B cells, was to potently suppress immune responses and alleviate asthmatic symptoms. 9, 11 Of note, the in vitro suppressive function of Treg-of-B1a cells was greater than that of reported Treg-of-B2 cells (Figure 1d) , and the surface molecules that were upregulated on Treg-of-B2 cells were also highly expressed by Treg-of-B1a cells (Figure 3c) . Therefore, the possibility that Treg-of-B1a cells might be able to regulate excessive immune response in vivo was of great expectation.
The finding that B-1a cells could convert naive T cells into Treg-of-B1a cells in vitro raised the question of whether there was a potential conversion of Treg-of-B1a cells in vivo. Recently, evidence suggested that B-1a cells from the peritoneal cavity are able to present antigen and communicate with T cells from the periphery. 37 The migration of B-1a cells to the periphery might facilitate B-1a-T contact, but this does not occur in abundant quantities. 38 On the other hand, i.v.-transferred CD4 1 T cells from the periphery migrate to the peritoneal cavity and come into contact with antigen-presenting B-1a cells. 37 At steady state, B-1a cells are largely present in the peritoneal cavity and have been found to acquire phagocytic capacities to sense commensal microbe-derived antigens. 39, 40 Correlated with this observation, peritoneal cavity T-cell populations have also been demonstrated to have an antigen-experienced/memory phenotype but with low frequency of Foxp3 1 Treg cells. 41 These findings indicate that to maintain intestinal homeostasis and tightly control the activated T cells, peritoneal B-1a might have an unexplored role on intestinal homeostasis that presents gut antigen to generate Treg cells. However, in the in vivo environment, other professional APCs, such as peritoneal DCs, might compete for antigen, and the frequency at which B-1a cells contact CD4
1 T cells might be relatively low compared with the in vitro culture system. In addition, the complicated cytokine environment in vivo might affect the induction process of Treg cells.
In our ongoing studies, we found that the suppressive function of Treg-of-B1a cells was gradually lost and that the surface molecules decreased when the cells were rested without stimulation for a few cycles of culture. Moreover, the rested Treg-ofB1a cells regained suppressive function after they were restimulated by antigen-loaded B-1a cells (data not shown). This observation suggested that when Treg-of-B1a cells are induced in vivo in response to immune activation, they might actively perform their effector function within a short period. However, following antigen clearance and due to the lack of contactdependent activation, Treg-of-B1a cells might became undetectable due to the downregulation of surface markers and loss of their suppressive function. By far, it is of utmost importance to identify the specified markers of Treg-of-B1a cells to examine of whether this population is present in vivo.
In Figure 2) . To our knowledge, this inducible Treg-of-B1a cell population had not been described before. Given that the immune modulatory roles of distinct B-cell subsets remain unclear, our data bring to light a new and not explored role of B-1a cells that does not involve IL-10.
